Skip to content

DIALECT, "DIAbetes and LifEstyle Cohort Twente"

DIALECT, "DIAbetes and LifEstyle Cohort Twente"

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON23767
Enrollment
850
Registered
2016-04-19
Start date
2009-08-31
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

NONE

Sponsors

Dr. G.D. Laverman Internal medicine/nephrology ZGT Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Male and female patients with type 2 diabetes • Patients aged 18 years or older • Follow-up taking place in the outpatient clinic internal medicine in the ZGT Hospital • Written informed consent

Exclusion criteria

Exclusion criteria: • Dependence on renal dialysis • Severe general diseases or mental disorders making the participation in the study impossible • Drug abuse (which will be assessed through anamnesis)

Design outcomes

Primary

MeasureTime frame
•All-cause mortality •Macrovascular disease: ocoronary disease: myocardial infarction, silent myocardial infarction, hospital admission for unstable angina pectoris or heart failure, coronary artery bypass graft, percutaneous coronary intervention oother: transient ischemic attack, cerebrovascular accident, diagnosis of peripheral vascular disease, peripheral bypass, percutaneous transluminal angioplasty, foot ulcers, amputation •Microvascular disease: diagnosis of diabetic retinopathy, diabetic neuropathy, nephropathy •Renal complications: nephropathy*, doubling of serum creatinine, start of renal replacement therapy

Secondary

MeasureTime frame
- blood pressure - kidney function - albuninurie

Contacts

Public ContactG.D. Laverman

ZGT Almelo

G.Laverman@zgt.nlTel: 088-7083079

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)